Scientists collect samples from COVID-19 patients to unlock virus secrets
NCT ID NCT04332016
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collected blood, urine, stool, and respiratory samples from 615 COVID-19 patients and caregivers at Bordeaux University Hospital. The goal was to build a biobank for research on the virus and disease. The study was terminated early, but the samples may still help scientists learn more about COVID-19.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this collection could help researchers better understand COVID-19 and improve future treatments or vaccines.
- What could go wrong
- This is a sample collection study, not a treatment trial. It was terminated early, so data may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
615 people
The number who actually took part.
- Started
-
Apr 2020
- Finished
-
Sep 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or symptomatic infection by SARS -CoV-2.
- Ages
-
Up to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or symptomatic infection by SARS -CoV-2 * men and women, adults and minors as well as pregnant or breastfeeding women * patients who died following infection with SARS-CoV-2 (specific criterion for post-mortem biopsies) * Be affiliated with or beneficiary of a social security scheme * Free and informed consent obtained and signed by the patient Exclusion Criteria: * Under guardianship or curatorship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infection viral are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, 33076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- French hospital staff antibody study reveals infection patterns
- New blood test aims to detect hidden infections in vulnerable patients
- New blood test could spot dangerous infections in feverish kids faster
- New biosensors aim to diagnose infections in minutes
- Can a simple blood test predict which COVID patients will get worse?
- Hospital COVID spread under the microscope: 2,000+ patients and staff tracked